1Doehner W, Schoene N, Rauchhaus M, et al. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies[J]. Circula
2Maack C, Kartes T, Kilter H, et al. Oxygen free radical release in human failing myocardium is associated with increased activity of Rac1-GTPase and represents a target for statin treatment[J]. Circulation , 2003, 108(13):1567-1574.
3Saavedra WF, Paolocci N, St John ME, et al. Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart[J]. Circ Res, 2002, 90(3): 297-304.
4Guan W, Osanai T, Kamada T, et al. Effect of allopurinol pretreatment on free radical generation after primary coronary angioplasty for acute myocardial infarction[J]. J Cardiovasc Pharmacol, 2003, 41(5): 699-705.
5Cicoira M, Zanolla L, Rossi A, et al. Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy[J]. Am Heart J, 2002, 143(6): 1107-1111.
6Cotton JM, Kearney MT, Shah AM. Nitric oxide and myocardial function in heart failure: friend or foe?[J]. Heart, 2002, 88(6): 564-566.
7Struthers AD, Donnan PT, Lindsay P, et al. Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study[J]. Heart, 2002, 87 (3): 229-234.
